Milestone
3.3.a
Harmonized endpoints
Not started
Develop a set of harmonized clinical end points—such as infection, severe disease, death, and potentially long COVID/PASC— and immunologic end points that can be used in vaccine efficacy studies for coronavirus vaccines to demonstrate protection against SARS-CoV-2 variants and “common cold” coronaviruses.